Interferon α may be back on track to treat acute myeloid leukemia

Our own experience and a thorough literature review suggest that interferon α (IFNα) should be reconsidered for the treatment of acute myeloid leukemia patients. Most likely, the success of such treatment depends on the achievement of high serum levels of IFNα for several months, which can be obtained by using pegylated IFNα.

[1]  Z. Berneman,et al.  Correction: Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential , 2014, PLoS ONE.

[2]  E. Smits,et al.  CD56 marks human dendritic cell subsets with cytotoxic potential , 2013, Oncoimmunology.

[3]  G. Guillerm,et al.  Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation , 2013, Annals of Hematology.

[4]  Z. Berneman,et al.  Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential , 2012, PloS one.

[5]  R. Schreiber,et al.  Type I interferon is selectively required by dendritic cells for immune rejection of tumors , 2011, The Journal of experimental medicine.

[6]  Z. Berneman,et al.  Interferon-α in acute myeloid leukemia: an old drug revisited , 2011, Leukemia.

[7]  Z. Berneman,et al.  Induction of complete remission of acute myeloid leukaemia by pegylated interferon‐α‐2a in a patient with transformed primary myelofibrosis , 2010, British journal of haematology.

[8]  W. Scherbaum,et al.  IFN-α Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo1 , 2008, The Journal of Immunology.

[9]  M. Wadhwa,et al.  Continuous delivery of human type I interferons (α/β) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model , 2007 .

[10]  M. Wadhwa,et al.  Continuous delivery of human type I interferons (alpha/beta) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model. , 2007, Blood.

[11]  R. Mesa,et al.  Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. , 2005, Blood.